Dialysis Equipment in Massachusetts

Summit International Medical Technologies is a specialty medical device manufacturer focused on critical care, anesthesia, dialysis, and neonatal markets. The company develops, manufactures, and distributes clinically innovative disposable and durable medical products designed to enhance patient safety and clinician efficiency while providing cost-effective care solutions. Key product lines include: Covalon AquaGuard moisture barrier systems for IV sites, PICC lines, and wound dressings; Parasol Medical fall prevention systems (wired and wireless) and DrySmart incontinence management pads; Starboard Medical temperature management probes for patient monitoring; Summit Medical AngelTip Safety Fistula for dialysis access; SternaSafe Uni sternum support braces for post-sternotomy recovery and SternaBra for women; Parasol Medical Cultivate quality assurance products for aseptic procedures; and NDI disposable marking spheres for surgical navigation and tracking. The company also acquired the Critical Concepts Inc. neonatal distribution product line in 2020, expanding its NICU offerings. Summit operates primarily in the United States, serving hospitals, critical care units, dialysis centers, and surgical facilities. The company emphasizes clinician-trusted, easy-to-use solutions with measurable clinical outcomes such as reduced complications, faster patient recovery, and improved safety. Products are designed for both acute hospital settings and post-operative care environments.

Quanta Dialysis Technologies manufactures the Quanta Dialysis System, an award-winning hemodialysis platform designed to deliver kidney replacement therapy across multiple care settings—acute care (ICU), post-acute facilities (LTAC, skilled nursing/rehabilitation), in-center chronic dialysis, and home-based self-care. The system is FDA-cleared (510(k) K222067 and K242269) to support multiple modalities—Intermittent Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), Continuous Renal Replacement Therapy (CRRT), and Prolonged Intermittent Renal Replacement Therapy (PIRRT)—from a single platform without the need for dialysate bags or daily rinses. Key clinical features include a wide blood flow range (Qd 50–500 mL/min), precision electrolyte control (sodium and potassium), and an intuitive touchscreen interface enabling rapid staff training (4.5–6 hours). The system weighs 71 lbs and features a compact, modular design suitable for resource-constrained or transitional care environments. Maintenance requires only once-weekly hot rinses, with no harsh chemical disinfections. The company received the prestigious Royal Academy of Engineering MacRobert Award in 2022 for on-demand dialysate technology. Home hemodialysis clearance (2024) permits patient use with a trained care partner, with >95% success rate in human factors testing and 84% patient retention post-trial. Blood tube sets are single-use, disposable accessories. Quanta serves hospitals, dialysis centers, long-term acute care facilities, skilled nursing facilities, rehabilitation centers, and home dialysis patients across North America and Europe.

M Dialysis AB is a Swedish medical device and research company specializing in clinical microdialysis solutions for intensive care monitoring and advanced pharmaceutical research. The company develops, manufactures, and markets a complete line of microdialysis instruments, consumables, and software used globally by hospitals, universities, and pharmaceutical companies for in vivo sampling and real-time monitoring of organs and tissues. M Dialysis serves clinicians and researchers seeking optimized patient care in ICU settings and accelerated drug development applications. The product portfolio includes the ISCUSflex microdialysis analyzer (the core analytical instrument), perfusion fluids, microvials, syringe kits, pump systems, and related consumables. The company is an offshoot of CMA Microdialysis AB, founded in 1984, and operates as a specialized provider in the narrow but clinically important niche of microdialysis technology. Applications span critical care monitoring, neurology, pharmacokinetics research, and tissue-specific biochemical assessment. The company maintains a global distribution network and serves as a research tool provider for pharmaceutical development and clinical decision support.

Precision Medical, Inc. is a global leader in the design and manufacturing of respiratory care equipment, headquartered in Northampton, Pennsylvania. Founded in 1982, this family-owned company employs approximately 125 people and generates annual revenue of $27.8 million. With over four decades of experience, Precision Medical specializes in precision-engineered respiratory solutions serving both acute care facilities and home care markets. The company manufactures an extensive portfolio of respiratory products including oxygen and medical air systems, vacuum regulators, flowmeters, oxygen conservers, medical blenders, aspirators, air compressors, and patient monitoring systems. Products are customizable to meet specific clinical requirements and are manufactured under rigorous quality standards, including MDSAP and ISO 13485:2016 certifications, ensuring compliance with international medical device manufacturing regulations. Precision Medical serves hospital emergency departments, ICU facilities, and home care patients with COPD and other respiratory conditions.